Literature DB >> 9478995

Regulation of the fibroblast growth factor receptor 3 promoter and intron I enhancer by Sp1 family transcription factors.

D G McEwen1, D M Ornitz.   

Abstract

Fibroblast growth factor receptor 3 (FGFR3) has a complex spatial and temporal pattern of expression and is essential for the normal development of a diverse set of tissues. Recently, mutations have been identified in FGFR3 that result in constitutive tyrosine kinase activity and cause a number of different human skeletal disorders. To examine the regulatory mechanisms governing FGFR3 expression, the promoter for the FGFR3 gene was identified and characterized. It resides in a CpG island, which encompasses the 5' end of the FGFR3 gene and lacks classical cis-regulatory motifs. As little as 100 base pairs of sequence 5' to the initiation site can confer a 20-40-fold increase in transcriptional activity upon a promoter-less vector. The transcriptional activity of these cis-regulatory sequences is further stimulated by elements found within the first intron. Mapping of the enhancer activity found within intron I identified two purine-rich sequence motifs between +340 and +395. Electrophoretic mobility shift assays demonstrated that sequences within this region bind members of the Sp1 family of transcription factors. In a background lacking Sp1-like activity, we demonstrate that Sp1 can enhance transcription of the minimal promoter (which contains five classical Sp1 sites), whereas both Sp1 and Sp3 can enhance transcription through the elements found in intron I. Although these transcription factors are ubiquitously expressed, we demonstrate that the sequences between -220 and +609 of the FGFR3 gene are sufficient to promote the tissue-specific expression of a reporter gene in transgenic mice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9478995     DOI: 10.1074/jbc.273.9.5349

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Modulation of DNA topoisomerase II alpha promoter activity by members of the Sp (specificity protein) and NF-Y (nuclear factor Y) families of transcription factors.

Authors:  Natisha Magan; Agnieszka P Szremska; Richard J Isaacs; Kathryn M Stowell
Journal:  Biochem J       Date:  2003-09-15       Impact factor: 3.857

2.  Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis.

Authors:  Jay W Shin; Michael Min; Fréderic Larrieu-Lahargue; Xavier Canron; Rainer Kunstfeld; Lynh Nguyen; Janet E Henderson; Andreas Bikfalvi; Michael Detmar; Young-Kwon Hong
Journal:  Mol Biol Cell       Date:  2005-11-16       Impact factor: 4.138

Review 3.  Achondroplasia: Development, pathogenesis, and therapy.

Authors:  David M Ornitz; Laurence Legeai-Mallet
Journal:  Dev Dyn       Date:  2017-03-02       Impact factor: 3.780

4.  Transcription factor Ikaros represses protein phosphatase 2A (PP2A) expression through an intronic binding site.

Authors:  Kamalpreet Nagpal; Katsue Sunahori Watanabe; Betty P Tsao; George C Tsokos
Journal:  J Biol Chem       Date:  2014-04-01       Impact factor: 5.157

5.  p53 binding prevents phosphatase-mediated inactivation of diphosphorylated c-Jun N-terminal kinase.

Authors:  Pramod S Gowda; Fuchun Zhou; Linda V Chadwell; Donald G McEwen
Journal:  J Biol Chem       Date:  2012-03-30       Impact factor: 5.157

6.  Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cells.

Authors:  Gayathri Chadalapaka; Indira Jutooru; Stephen Safe
Journal:  Carcinogenesis       Date:  2012-02-14       Impact factor: 4.944

7.  NFATc1 regulates lymphatic endothelial development.

Authors:  Rishikesh M Kulkarni; James M Greenberg; Ann L Akeson
Journal:  Mech Dev       Date:  2009-02-20       Impact factor: 1.882

Review 8.  Cellular targeting for cochlear gene therapy.

Authors:  Allen F Ryan; Lina M Mullen; Joni K Doherty
Journal:  Adv Otorhinolaryngol       Date:  2009-06-02

9.  Augmentation of Smad-dependent BMP signaling in neural crest cells causes craniosynostosis in mice.

Authors:  Yoshihiro Komatsu; Paul B Yu; Nobuhiro Kamiya; Haichun Pan; Tomokazu Fukuda; Gregory J Scott; Manas K Ray; Ken-Ichi Yamamura; Yuji Mishina
Journal:  J Bone Miner Res       Date:  2013-06       Impact factor: 6.741

10.  Remodeling of chromatin structure within the promoter is important for bmp-2-induced fgfr3 expression.

Authors:  Fenyong Sun; Qiongyu Chen; Songhai Yang; Qiuhui Pan; Ji Ma; Yang Wan; Chih-Hao Chang; An Hong
Journal:  Nucleic Acids Res       Date:  2009-04-28       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.